BIOTECHNOLOGY VALUE FUND L P

SAN FRANCISCO, CA Hedge Fund How do I update this listing?

Biotechnology Value Fund L P is based out of San Francisco. Whalewisdom has at least 96 13D filings, 527 13G filings, and 1 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-01-10. The filing was for a pooled investment fund: hedge fund The notice included securities offered of Pooled Investment Fund Interests

Create Email Alert

Contact Info

biotechnology value fund l p
44 MONTGOMERY STREET
SAN FRANCISCO CA    94104

Business Phone: 3125066500
SEC SIC CODE:
6282-INVESTMENT ADVICE
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Principia Biopharma Inc (PRNB) HEALTH CARE 1,716,734 101,939,664.92 1 13G 2019-12-31
Calliditas Therapeutics AB|Calliditas Th (CALT) 4,781,562 93,718,615.20 2 13G 2020-06-05
XBiotech, Inc. (unknown) 1,750,000 86,642,500.00 3 13G 2017-04-13
Xoma Corporation (XOMA) HEALTH CARE 4,026,157 85,555,836.25 4 13D 2020-04-15
SpringWorks Therapeutics Inc (SWTX) HEALTH CARE 3,079,155 83,137,185.00 5 13G 2019-12-31
Forward Pharma A/S ADR (FWP) HEALTH CARE 14,092,736 79,187,083.58 6 13G 2019-12-31
AC Immune SA (ACIU) HEALTH CARE 11,342,505 78,376,709.55 7 13G 2019-12-31
Merus BV (MRUS) HEALTH CARE 4,990,571 68,121,294.15 8 13G 2020-06-01
Cascadian Therapeutics, Inc. (CASC) HEALTH CARE 6,008,224 60,202,404.48 9 13G 2017-02-02
Realm Therapeutics PLC (RLM) HEALTH CARE 21,451,171 53,627,927.50 10 13G 2018-12-31
Arcus Biosciences Inc (RCUS) HEALTH CARE 3,579,023 49,676,839.24 11 13G 2019-12-31
Molecular Templates Inc (MTEM) HEALTH CARE 3,608,332 47,954,732.28 12 13G 2019-12-31
Cytokinetics Inc (CYTK) HEALTH CARE 3,938,280 46,432,321.20 13 13G 2020-03-30
Ideaya Biosciences Inc (IDYA) HEALTH CARE 3,224,172 45,960,571.86 14 13G 2020-06-18
Calithera Biosciences Inc (CALA) HEALTH CARE 7,090,638 43,465,610.94 15 13G 2020-05-21
Xenon Pharmaceuticals Inc (XENE) HEALTH CARE 3,516,851 41,534,010.31 16 13G 2020-06-16
Syndax Pharmaceuticals Inc (SNDX) HEALTH CARE 2,816,390 30,895,798.30 17 13G 2019-12-31
Celldex Therapeutics Inc. (CLDX) HEALTH CARE 2,740,000 28,085,000.00 18 13G 2020-06-16
CytomX Therapeutics Inc (CTMX) HEALTH CARE 3,188,948 24,459,231.16 19 13G 2020-02-25
Erytech Pharma SA ADR (ERYP) HEALTH CARE 4,547,662 24,284,515.08 20 13D 2018-11-06
Kura Oncology Inc (KURA) HEALTH CARE 2,434,696 24,225,225.20 21 13G 2020-03-06
Replimune Group Inc (REPL) HEALTH CARE 2,309,109 23,021,816.73 22 13G 2019-12-31
Mersana Therapeutics Inc (MRSN) HEALTH CARE 3,755,553 21,894,873.99 23 13G 2019-12-31
Sutro Biopharma Inc (STRO) HEALTH CARE 2,368,392 20,983,953.12 24 13G 2020-05-12
AnaptysBio Inc (ANAB) HEALTH CARE 1,441,565 20,369,313.45 25 13G 2020-01-23
Five Prime Therapeutics Inc (FPRX) HEALTH CARE 7,783,001 17,667,412.27 26 13D 2019-12-20
GlycoMimetics Inc (GLYC) HEALTH CARE 7,361,801 16,784,906.28 27 13G 2019-12-31
Verastem Inc (VSTM) HEALTH CARE 6,328,994 16,708,544.16 28 13G 2019-12-31
Protagonist Therapeutics Inc (PTGX) HEALTH CARE 2,332,630 16,468,367.80 29 13G 2019-12-31
Spero Therapeutics Inc (SPRO) HEALTH CARE 2,028,405 16,389,512.40 30 13G 2019-12-31
Ovid Therapeutics Inc (OVID) HEALTH CARE 5,255,301 15,660,796.98 31 13G 2019-12-31
Infinity Pharmaceuticals Inc (INFI) HEALTH CARE 17,426,968 14,638,653.12 32 13D 2020-01-08
Pieris Pharmaceuticals Inc (PIRS) HEALTH CARE 5,872,762 13,389,897.36 33 13G 2020-02-14
Selecta Biosciences Inc (SELB) HEALTH CARE 4,926,108 11,871,920.28 34 13G 2019-12-23
CTI BioPharma Corp (CTIC) HEALTH CARE 12,753,690 11,733,394.80 35 13D 2020-03-02
MEI Pharma Inc (MEIP) HEALTH CARE 6,886,425 11,087,144.25 36 13G 2019-12-31
Essa Pharma Inc (EPIX) HEALTH CARE 2,640,565 10,562,260.00 37 13G 2019-12-31
Kezar Life Sciences Inc (KZR) HEALTH CARE 2,039,788 8,893,475.68 38 13G 2020-01-31
Regado BioSciences, Inc. (TBRA) HEALTH CARE 209,148 8,803,923.21 39 13G 2014-12-31
Cidara Therapeutics Inc (CDTX) HEALTH CARE 3,368,758 8,354,519.84 40 13G 2019-12-31
Galmed Pharmaceuticals Ltd (GLMD) HEALTH CARE 1,832,484 6,340,394.64 41 13G 2019-12-31
Corvus Pharmaceuticals Inc (CRVS) HEALTH CARE 2,921,177 6,163,683.47 42 13G 2019-12-31
Surface Oncology Inc (SURF) HEALTH CARE 2,125,650 5,654,229.00 43 13G 2020-05-19
Genocea Biosciences Inc (GNCA) HEALTH CARE 3,161,668 5,438,068.96 44 13G 2019-12-31
Curis Inc (CRIS) HEALTH CARE 3,650,000 4,891,000.00 45 13G 2020-06-11
Sunesis Pharmaceuticals Inc (SNSS) HEALTH CARE 11,653,925 4,778,109.25 46 13G 2019-12-31
BioLine RX Ltd (BLRX) HEALTH CARE 2,082,831 3,603,297.63 47 13G 2020-05-28
Alpine Immune Sciences Inc (ALPN) HEALTH CARE 1,137,764 3,276,760.32 48 13G 2019-12-31
Forte Biosciences Inc (TOCA) HEALTH CARE 72,702 1,374,064.69 49 13G 2020-06-15
Regulus Therapeutics Inc (RGLS) HEALTH CARE 2,096,708 964,485.68 50 13G 2019-12-31
Spring Bank Pharmaceuticals Inc (SBPH) HEALTH CARE 951,701 885,081.93 51 13G 2019-12-31
Novus Therapeutics Inc (NVUS) HEALTH CARE 1,336,556 521,256.84 52 13G 2019-04-30
Brickell Biotech Inc (BBI) HEALTH CARE 325,678 387,556.26 53 13G 2019-04-08
GlobeImmune Inc (GBIM) HEALTH CARE 657,653 157,836.72 54 13G 2015-12-31
Aeolus Pharmaceutical (AOLS) HEALTH CARE 15,213,480 152,134.80 55 13G 2015-12-31
Anthera Pharmaceuticals Inc (ANTH) HEALTH CARE 1,658,157 49,744.71 56 13G 2017-12-31
Orexigen Therapeutics Inc (OREXQ) HEALTH CARE 2,036,860 20,368.60 57 13G 2018-12-31
X4 PHARMACEUTICALS ORD SHS (XFOR) 1,660,475 58 13G 2019-12-31
BRICKELL BIOTECH ORD SHS (BBI) 664,079 59 13G 2019-12-31
Repare Therapeutics Inc. (RPTX) 1,944,546 60 13G 2020-06-19

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-01-10 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 413,832,682 INDEFINITE
2019-01-11 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 224,032,682 INDEFINITE
2017-12-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 224,032,682 INDEFINITE
2016-09-21 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 212,032,682 INDEFINITE
2014-11-12 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 64,755,500 INDEFINITE
2013-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 41,655,500 INDEFINITE
2012-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 37,655,500 INDEFINITE
2011-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 36,155,500 INDEFINITE
2010-10-21 D POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 34,905,500 INDEFINITE
2009-10-15 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 29,155,500 INDEFINITE
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
JAMES KRATKY subscription required
    EXECUTIVE OFFICER
JASON MCCUNE subscription required
    EXECUTIVE OFFICER
MARC N. LAMPERT subscription required
    EXECUTIVE OFFICER
MARK N LAMPERT subscription required
    EXECUTIVE OFFICER
MATTHEW D PERRY subscription required
    EXECUTIVE OFFICER
MITCHELL KAYE subscription required
    EXECUTIVE OFFICER
N/A BVF INC. subscription required
    EXECUTIVE OFFICER
N/A BVF PARTNERS, L.P. subscription required
    EXECUTIVE OFFICER
OLEG NODELMAN subscription required
    EXECUTIVE OFFICER
SPIKE LOY subscription required
    EXECUTIVE OFFICER

Elevate your investments